CHICAGO, Aug. 20, 2013 /PRNewswire/ -- The highly-anticipated Allscripts Wand™ 2.0 for Enterprise EHR is now generally available. In a busy physician practice, clinicians and physicians are moving quickly from patient to patient. Efficient throughput is essential to their operational success. Wand is the native iPad™ application that couples the latest in tablet technology with the latest in user-experience innovation for a revolutionary approach to how physicians practice medicine.
Allscripts will be demoing the latest version of Wand this week at The Allscripts Client Experience (ACE), August 21-23 at Chicago's McCormick Place.
This enhanced version of Wand contains the functionality that clinicians and physicians alike need to complete a patient visit with one mobile device. Whether it's reviewing the patient chart before entering the exam room, updating the patient's history during a consultation, refilling electronic prescriptions while rounding in the hospital or reviewing the next day's appointments from home, Wand supports the physician's workflow, wherever he or she is. Wand was built to help physicians collect the electronic information they need without interfering with the important physician-patient relationship.
"Wand for Enterprise offers physicians flexibility," said Dr. Brian Keeffe, a cardiologist and Chief Medical Advisor for Electronic Health Records at Marin Medical Practice Concepts. "The ability to create notes on the go when you are seeing up to 25 patients per day is invaluable."
Other key features of the enhanced version of Wand include:
- Complete Clinical documentation
- Place all types of orders
- Easily attach photos to a patient's chart
- Drop visit charges
"We listened to our clients and broke new ground with the 2.0 version of Wand for Enterprise," said Stanley Crane, Chief Innovation Officer for Allscripts. "What we have delivered is a mobile tool with a streamlined workflow and faster access to critical data – where and when the physicians need it most – in their hands at the point of care."
Wand for Enterprise is the latest in a long line of mobility innovation from Allscripts. Wand for Professional was unveiled in April 2012. In 2010, the company released Sunrise Mobile MDII for iPad, giving hospitals providers remote access to many daily activities, expanding on Sunrise Mobile MD for iPhone™. And with Allscripts Remote, available since 2009, ambulatory EHR users can access key clinical features after hours on virtually any smartphone. Wand for Enterprise takes the next step by adding more features and a native iPad interface to put essential clinical information at the fingertips of the mobile healthcare professional.
For more information or to download the application, visit the iTunes App Store.
About Allscripts
Allscripts (NASDAQ: MDRX) delivers the insights that healthcare providers require to generate world-class outcomes. The company's Electronic Health Record, practice management and other clinical, revenue cycle, connectivity and information solutions create a Connected Community of Health™ for physicians, hospitals and post-acute organizations. To learn more about Allscripts, please visit www.allscripts.com, Twitter, YouTube and It Takes A Community: The Allscripts Blog.
© 2013 Allscripts Healthcare, LLC. All Rights Reserved.
Allscripts, the Allscripts logo, and other Allscripts marks are either registered trademarks or trademarks of Allscripts Healthcare, LLC in the United States and/or other countries. All other trademarks are the property of their respective owners.
Forward-Looking Statements
This press release contains forward-looking statements within the meaning of the federal securities laws. Statements regarding future events or developments, our future performance, as well as management's expectations, beliefs, intentions, plans, estimates or projections relating to the future are forward-looking statements with the meaning of these laws. These forward-looking statements are subject to a number of risks and uncertainties, some of which are outlined below. As a result, no assurances can be given that any of the events anticipated by the forward-looking statements will transpire or occur, or if any of them do so, what impact they will have on our results of operations or financial condition. Such risks, uncertainties and other factors include, among other things: the possibility that our current initiatives focused on product delivery, client experience, streamlining our cost structure, and financial performance may not be successful, which could result in declining demand for our products and services, including attrition among our existing customer base; the impact of the realignment of our sales and services organization; potential difficulties or delays in achieving platform and product integration and the connection and movement of data among hospitals, physicians, patients and others; the risks that we will not achieve the strategic benefits of the merger with Eclipsys Corporation (Eclipsys) or our acquisition of dbMotion, Ltd. (dbMotion), or that the Allscripts products will not be integrated successfully with the Eclipsys and dbMotion products; competition within the industries in which we operate, including the risk that existing clients will switch to products of competitors; failure to maintain interoperability certification pursuant to the Health Information Technology for Economic and Clinical Health Act (HITECH), with resulting increases in development and other costs for us and possibly putting us at a competitive disadvantage in the marketplace; the volume and timing of systems sales and installations, the length of sales cycles and the installation process and the possibility that our products will not achieve or sustain market acceptance; the timing, cost and success or failure of new product and service introductions, development and product upgrade releases; any costs or customer losses we may incur relating to the standardization of our small office electronic health record and practice management systems that could adversely affect our results of operations; competitive pressures including product offerings, pricing and promotional activities; our ability to establish and maintain strategic relationships; errors or similar problems in our software products or other product quality issues; the outcome of any legal proceeding that has been or may be instituted against us and others; compliance obligations under new and existing laws, regulations and industry initiatives, including new regulations relating to HIPAA/HITECH, increasing enforcement activity in respect of anti-bribery, fraud and abuse, privacy, and similar laws, and future changes in laws or regulations in the healthcare industry, including possible regulation of our software by the U.S. Food and Drug Administration; the possibility of product-related liabilities; our ability to attract and retain qualified personnel; the continued implementation and ongoing acceptance of the electronic record provisions of the American Recovery and Reinvestment Act of 2009, as well as elements of the Patient Protection and Affordable Care Act (aka health reform) which pertain to healthcare IT adoption, including uncertainty related to changes in reimbursement methodology and the shift to pay-for-outcomes; maintaining our intellectual property rights and litigation involving intellectual property rights; legislative, regulatory and economic developments; risks related to third-party suppliers and our ability to obtain, use or successfully integrate third-party licensed technology; breach of data security by third parties and unauthorized access to patient health information by third parties resulting in enforcement actions, fines and other litigation. See our Annual Report on Form 10-K/10K-A for 2012 and other public filings with the SEC for a further discussion of these and other risks and uncertainties applicable to our business. The statements herein speak only as of their date and we undertake no duty to update any forward-looking statement whether as a result of new information, future events or changes in expectations.
(Logo: http://photos.prnewswire.com/prnh/20100901/CG58147LOGO)
SOURCE Allscripts Healthcare Solutions, Inc.
Investors, Seth Frank, 312-506-1213, seth.frank@allscripts.com, or Media, Claire Weingarden, 312-447-2442, claire.weingarden@allscripts.com
